{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:03:36Z","timestamp":1788930216774,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.neuro.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T18:07:22Z","timestamp":1679594842000},"page":"37-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and \u03b1-synuclein expressions in rats"],"prefix":"10.1016","volume":"96","author":[{"given":"I.O.","family":"Ishola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.O.","family":"Awogbindin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.G.","family":"Olubodun-Obadun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Olajiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.O.","family":"Adeyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuro.2023.03.002_bib1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s11011-019-00478-1","article-title":"Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells","volume":"34","author":"Alabi","year":"2019","journal-title":"Metabolic brain disease"},{"issue":"1","key":"10.1016\/j.neuro.2023.03.002_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5271\/sjweh.3466","article-title":"Neurological outcomes associated with low-level manganese exposure in an inception cohort of asymptomatic welding trainees","volume":"41","author":"Baker","year":"2015","journal-title":"Scandinavian journal of work, environment & health"},{"issue":"12","key":"10.1016\/j.neuro.2023.03.002_bib3","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1177\/0271678X19895432","article-title":"Reduced cerebral blood flow in an \u03b1-synuclein transgenic mouse model of Parkinson's disease","volume":"40","author":"Biju","year":"2020","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuro.2023.03.002_bib4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/bonekey.2015.101","article-title":"Assessment of muscle mass and strength in mice","volume":"4","author":"Bonetto","year":"2015","journal-title":"BoneKEy reports"},{"issue":"1\u20132","key":"10.1016\/j.neuro.2023.03.002_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0929-8266(02)00006-X","article-title":"Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study","volume":"15","author":"B\u00f6n\u00f6czk","year":"2002","journal-title":"Eur. J. Ultrasound"},{"key":"10.1016\/j.neuro.2023.03.002_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2018.12.012","article-title":"Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease","volume":"135","author":"Dodiya","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2023.03.002_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuro.2019.03.005","article-title":"Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson\u2019s disease","volume":"73","author":"Farombi","year":"2019","journal-title":"Neurotoxicology"},{"issue":"suppl 1","key":"10.1016\/j.neuro.2023.03.002_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000116721","article-title":"Neuropathology of the substantia nigra","volume":"31","author":"Gibb","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neuro.2023.03.002_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson's disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu Rev. Pharm. Toxicol."},{"issue":"Pt 2","key":"10.1016\/j.neuro.2023.03.002_bib10","article-title":"Rotenone impairs learning and memory in mice through microglia-mediated blood brain barrier disruption and neuronal apoptosis","volume":"291","author":"Guo","year":"2022","journal-title":"Chemosphere"},{"issue":"7","key":"10.1016\/j.neuro.2023.03.002_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s11011-020-00584-5","article-title":"Amelioration of motor and non-motor deficits and increased striatal APoE levels highlight the beneficial role of pistachio supplementation in rotenone-induced rat model of PD","volume":"35","author":"Haider","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuro.2023.03.002_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2017.01.012","article-title":"Dementia in Parkinson's disease","volume":"374","author":"Hanagasi","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2023.03.002_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bph.15684","article-title":"Targeting \u03b1-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease","volume":"179","author":"Haque","year":"2022","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.neuro.2023.03.002_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.28075","article-title":"Ten unsolved questions about neuroinflammation in Parkinson's disease","volume":"36","author":"Hirsch","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2023.03.002_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-synuclein oligomers-neurotoxic molecules in Parkinson's disease and other lewy body disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front Neurosci."},{"issue":"2","key":"10.1016\/j.neuro.2023.03.002_bib16","first-page":"203","article-title":"Vinpocetine prevents haloperidol-induced cognitive and working memory deficits through attenuation of oxidative and nitrosative stress in mice","volume":"35","author":"Ishola","year":"2020","journal-title":"Niger. J. Physiol. Sci."},{"issue":"6","key":"10.1016\/j.neuro.2023.03.002_bib17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/fcp.12567","article-title":"Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system","volume":"34","author":"Ishola","year":"2020","journal-title":"Fundam. Clin. Pharm."},{"issue":"3","key":"10.1016\/j.neuro.2023.03.002_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/jbcpp-2014-0015","article-title":"Role for monoaminergic systems in the antidepressant and anxiolytic properties of the hydroethanolic leaf extract from Adenia cissampeloides","volume":"26","author":"Ishola","year":"2015","journal-title":"J. Basic Clin. Physiol. Pharm."},{"issue":"5","key":"10.1016\/j.neuro.2023.03.002_bib19","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11011-018-0256-9","article-title":"Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation","volume":"33","author":"Ishola","year":"2018","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.neuro.2023.03.002_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12640-019-00117-8","article-title":"Diastereomeric mixture of calophyllic and isocalophyllic acid ameliorates scopolamine-induced memory impairment in mice: involvement of antioxidant defense and cholinergic systems","volume":"37","author":"Ishola","year":"2020","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.neuro.2023.03.002_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.neuro.2023.03.002_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","article-title":"Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies","volume":"125","author":"Jellinger","year":"2018","journal-title":"J. Neural Transm."},{"issue":"Suppl 7","key":"10.1016\/j.neuro.2023.03.002_bib23","article-title":"Weight loss in Parkinson's disease","volume":"253","author":"Kashihara","year":"2006","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.neuro.2023.03.002_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","article-title":"Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors","volume":"11","author":"Klingelhoefer","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.neuro.2023.03.002_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1515\/revneuro-2021-0173","article-title":"Probiotic effects on anxiety-like behavior in animal models","volume":"33","author":"Lalonde","year":"2022","journal-title":"Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neuro.2023.03.002_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0021-9258(18)71242-8","article-title":"The quantitative histochemistry of brain. II. Enzyme measurements","volume":"207","author":"Lowry","year":"1954","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"10.1016\/j.neuro.2023.03.002_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"Journal of neuroscience methods"},{"issue":"8","key":"10.1016\/j.neuro.2023.03.002_bib28","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/life11080732","article-title":"The baseline structure of the enteric nervous system and its role in Parkinson's disease","volume":"11","author":"Natale","year":"2021","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.neuro.2023.03.002_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41575-020-00385-2","article-title":"Disorders of the enteric nervous system - a holistic view","volume":"18","author":"Niesler","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.neuro.2023.03.002_bib30","first-page":"384","article-title":"Fatigue and weight loss in Parkinson's disease","volume":"64","author":"Okuma","year":"2012","journal-title":"Brain Nerve"},{"key":"10.1016\/j.neuro.2023.03.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2020.104753","article-title":"The effect of ethion on erythrocyte deformability","volume":"172","author":"\u00d6zkul","year":"2021","journal-title":"Pest. Biochem Physiol."},{"key":"10.1016\/j.neuro.2023.03.002_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","article-title":"Complex I deficiency in Parkinson's disease frontal cortex","volume":"1189","author":"Parker","year":"2008","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.neuro.2023.03.002_bib33","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.parkreldis.2015.10.011","article-title":"Gastric motor dysfunctions in Parkinson's disease: current pre-clinical evidence","volume":"21","author":"Pellegrini","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.neuro.2023.03.002_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice","volume":"68","author":"Perez-Pardo","year":"2019","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.neuro.2023.03.002_bib35","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson's disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"Pt B","key":"10.1016\/j.neuro.2023.03.002_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.neuro.2023.03.002_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuro.2023.03.002_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease","volume":"106-107","author":"Subramaniam","year":"2013","journal-title":"Progress in neurobiology"},{"key":"10.1016\/j.neuro.2023.03.002_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jns.2004.11.053","article-title":"Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study","volume":"229\u2013230","author":"Szil\u00e1gyi","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.neuro.2023.03.002_bib40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.5692\/clinicalneurol.49.885","article-title":"Pathogenesis of sporadic Parkinson's disease: contribution of genetic and environmental risk factors","volume":"49","author":"Takahashi","year":"2009","journal-title":"Rinsho Shinkeigaku"},{"issue":"2","key":"10.1016\/j.neuro.2023.03.002_bib41","first-page":"367","article-title":"Abnormal accumulation of NACP\/alpha-synuclein in neurodegenerative disorders","volume":"152","author":"Takeda","year":"1998","journal-title":"Am J Pathol."},{"issue":"2","key":"10.1016\/j.neuro.2023.03.002_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/13813455.2019.1620288","article-title":"Metformin protects red blood cells against rotenone-induced oxidative stress and cytotoxicity","volume":"127","author":"Tripathi","year":"2021","journal-title":"Arch. Physiol. Biochem"},{"issue":"1","key":"10.1016\/j.neuro.2023.03.002_bib43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-018-1286-2","article-title":"Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease","volume":"15","author":"Williams","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.neuro.2023.03.002_bib44","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain\u202f: a journal of neurology"},{"key":"10.1016\/j.neuro.2023.03.002_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.917499","article-title":"New understanding on the pathophysiology and treatment of constipation in Parkinson's disease","volume":"14","author":"Xu","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.neuro.2023.03.002_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yrtph.2018.05.005","article-title":"Pesticide exposure and risk of Parkinson's disease: dose-response meta-analysis of observational studies","volume":"96","author":"Yan","year":"2018","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.neuro.2023.03.002_bib47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2017.11.041","article-title":"An update on vinpocetine: new discoveries and clinical implications","volume":"819","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharm."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X23000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X23000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T21:56:01Z","timestamp":1736373361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X23000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":47,"alternative-id":["S0161813X23000438"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2023.03.002","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and \u03b1-synuclein expressions in rats","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}